Trial Profile
Retrospective study of Posaconazole and Sirolimus in allogenic hematopoietic stem cell transplantation patients with graft versus host disease (GVHD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary) ; Sirolimus
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 03 Feb 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology